While number staging is widely used, it has its limitations. It may not capture the full complexity of certain cancers, particularly those that are biologically diverse. Additionally, number staging does not always account for molecular and genetic factors that can influence the behavior and treatment response of cancer. As a result, there is a growing emphasis on personalized medicine, which tailors treatment based on the individual's unique cancer profile.
